Skip to content

Use of the Nasal Cannula During COVID-19

Incidence and Implications With the Use of Nasal Cannulas During COVID-19

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04376580
Enrollment
100
Registered
2020-05-06
Start date
2020-04-30
Completion date
2020-11-30
Last updated
2020-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID 19

Keywords

Low flow nasal cannula, Anesthesia, Sedation, Regional Anesthesia

Brief summary

The objective of this investigation is to determine the incidence of the use of the low flow nasal cannula in suspected or confirmed cases with Covid-19

Detailed description

An anonymous questionnaire will be sent to a group of anesthesiologists via email which will allow to collect information about the use, or not, of the low flow nasal cannula, the type of procedure where it is used, and the type of personal protection weared.

Interventions

None listed

Sponsors

Tiva Group
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* only for physicians

Exclusion criteria

* not physicians

Design outcomes

Primary

MeasureTime frameDescription
Number of physician using los flow nasal cannula during COVID 19 pandemia1 monthWe'll send by email a link with an online quiz to a Group of physicians with questions related to the use of nasal cannula during their routine practice.

Secondary

MeasureTime frameDescription
Number of physician getting sick during Covid 19 pandemic1 monthWe'll send by email a link with an online quiz to a group of physicians with questions related to the use of nasal cannula during their routine practice, and one of the questions is about if the physician was getting sick during the Covid pandemic.

Countries

Argentina

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026